Given the role of AT1R in fundamental physiological processes and interactions with known cancer-related signalling pathways, it is unsurprising that AT1R dysregulation has been implicated in cancer development, progression, and response to anti-cancer therapy [7]. This evidence concerns the gene AGTR1 and cancer.